U.S., April 3 -- ClinicalTrials.gov registry received information related to the study (NCT06906029) titled 'Abdominal aBscess Catheter Sclerotherapy (ABCS)' on March 19.
Brief Summary: This is a single center, two arm phase I/II clinical trial exploring the use of chemical sclerosants (ethanol and povidone iodine) in decreasing the time needed for catheter drainage for patients with non-fistulous intraabdominal abscesses. The target study sample size is 60 patients, 30 in each arm and abscess size is to be a minimum of 3cm in all 3 dimensions. The primary outcomes of interest will be tolerability and need for catheter reinsertion by one week post intervention.
Study Start Date: July, 2025
Study Type: INTERVENTIONAL
Condition:
Abdomina...